Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,640,193
+$9,081,240 QoQ
Shares Held
118,627
+20.3% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
13.52%
of 13F equity value
Holder Rank
#62
of 308 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Resolute Capital Asset Partners LLC holds $62,675,846 across 8 Biotechnology names. ASND ranks #1 (50.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
118,627 | $31,640,193 | |
| 2 | ARGX |
Argenx SE
|
12,000 | $11,133,240 | |
| 3 | LEGN |
Legend Biotech Corp
|
260,871 | $7,533,954 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
30,000 | $3,512,100 | |
| 5 | CELC |
Celcuity Inc.
|
30,000 | $3,138,600 | |
| 6 | ABVX |
Abivax S.A.
|
17,500 | $2,332,050 | |
| 7 | KOD |
Kodiak Sciences Inc.
|
51,385 | $2,001,959 | |
| 8 | REPL |
Replimune Group, Inc.
|
125,000 | $1,383,750 |
All Filings in ASND
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,640,193 | 118,627 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,558,953 | 98,627 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,898,821 | 88,627 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,937,250 | 165,672 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,731,987 | 160,672 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,106,550 | 167,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,763,215 | 114,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,602,895 | 104,500 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,409,860 | 47,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,104,990 | 47,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,584,580 | 36,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,511,500 | 37,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,346,875 | 37,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,020,750 | 37,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,579,875 | 37,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,097,800 | 30,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,859,200 | 20,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,347,200 | 20,000 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||